<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2000 (8) TMI 861 - CEGAT, NEW DELHI</title>
    <link>https://www.taxtmi.com/caselaws?id=99172</link>
    <description>Classification turned on the products&#039; essential medicinal character and intended therapeutic use, not on attractive packaging or the presence of excipients, preservatives, fragrances, or other subsidiary cosmetic features; on that basis, the identified products were treated as ayurvedic medicaments, while the remaining products fell under cosmetics and toilet preparations. Related-person valuation required proof that common ownership or directorship actually influenced price, and comparable sales indicated no such influence; the manufacturer&#039;s price remained the valuation basis, subject to cum-duty treatment where duty was not separately recovered. The extended limitation period was unavailable because suppression or wilful misstatement was not established, so the demand beyond the normal period was time-barred.</description>
    <language>en-us</language>
    <pubDate>Mon, 28 Aug 2000 00:00:00 +0530</pubDate>
    <lastBuildDate>Wed, 25 Jan 2012 14:39:35 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=136229" rel="self" type="application/rss+xml"/>
    <item>
      <title>2000 (8) TMI 861 - CEGAT, NEW DELHI</title>
      <link>https://www.taxtmi.com/caselaws?id=99172</link>
      <description>Classification turned on the products&#039; essential medicinal character and intended therapeutic use, not on attractive packaging or the presence of excipients, preservatives, fragrances, or other subsidiary cosmetic features; on that basis, the identified products were treated as ayurvedic medicaments, while the remaining products fell under cosmetics and toilet preparations. Related-person valuation required proof that common ownership or directorship actually influenced price, and comparable sales indicated no such influence; the manufacturer&#039;s price remained the valuation basis, subject to cum-duty treatment where duty was not separately recovered. The extended limitation period was unavailable because suppression or wilful misstatement was not established, so the demand beyond the normal period was time-barred.</description>
      <category>Case-Laws</category>
      <law>Central Excise</law>
      <pubDate>Mon, 28 Aug 2000 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=99172</guid>
    </item>
  </channel>
</rss>